The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on June 1, 2026

Jun. 1, 2026

Certiprof Establishes New AI Certification Pathway for IT Personnel to Match 2026 Job Market Demands

Indeterminate EIN Presswire

Jun. 1, 2026

PLEXIS Highlights Composable CAPS to Assist Health Plans to Modernize Legacy Core Administration with Minimal Disruption

Indeterminate EIN Presswire

Jun. 1, 2026

EIN Presswire Announces June Special on Press Release Distribution Packages

Indeterminate EIN Presswire

Jun. 1, 2026

Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea

Indeterminate GlobeNewswire

Jun. 1, 2026

Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Praxis Precision Medicines Provides Vormatrigine Program Update

Indeterminate GlobeNewswire

Jun. 1, 2026

XS.com Conquista o Prêmio de “Melhor Programa de IB” na Wealth Expo Colombia 2026

Indeterminate EIN Presswire

Jun. 1, 2026

XS.com gana el premio “Mejor Programa de IB” en Wealth Expo Colombia 2026

Indeterminate EIN Presswire

Jun. 1, 2026

Royalton Vessence Barbados is Now Open, Introducing a Transformative New All-Inclusive Resort Concept

Indeterminate GlobeNewswire

Jun. 1, 2026

Orano Increases Ownership in Cigar Lake Mine in Canada

Indeterminate GlobeNewswire

Jun. 1, 2026

AMAX Accelerates AI Factory Performance with New Intel Xeon 6+ Processors

Indeterminate EIN Presswire

Jun. 1, 2026

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

Indeterminate GlobeNewswire

Jun. 1, 2026

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Ticketplus Files Registration Statement with the U.S. Securities and Exchange Commission (SEC) for Proposed Initial Public Offering

Indeterminate GlobeNewswire

Jun. 1, 2026

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Indeterminate GlobeNewswire

Jun. 1, 2026

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Indeterminate GlobeNewswire

Jun. 1, 2026

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

Indeterminate GlobeNewswire

Jun. 1, 2026

Belo Sun Announces Corporate Update

Indeterminate GlobeNewswire